The United States has donated an additional 10 million (1 crore) doses of Pfizer’s COVID-19 vaccine to Bangladesh as a gift from the American people.   Delivered via COVAX, these donations of Pfizer vaccines bring the total U.S. government vaccine contribution to more than 38.6 million (3.86 crore) doses. “With the latest spike in COVID-19 infections, the United States is redoubling our efforts to help Bangladesh turn the tide against this surge," said U.S. Chargé d’Affaires Helen LaFave on Monday.  These doses will help expand vaccinations for students and those who are awaiting their first doses, while enabling vulnerable people to receive boosters to protect themselves against the growing presence of the Omicron variant, said the US diplomat. Read: US donates additional 9.6 million Pfizer vaccine doses to Bangladesh This delivery of Pfizer vaccines is part of the United States’ commitment to lead the global COVID-19 response by donating a billion doses of Pfizer vaccine around the world through 2022.  The US side says millions more doses are scheduled to arrive here over the coming months. In addition to vaccine donations, the United States continues to work closely with Bangladesh to support the national COVID-19 vaccination campaign and strengthen the government’s response to the pandemic.   The United States has provided training to over 7,000 healthcare providers on the proper management and administration of vaccines. To date, the United States has contributed over $121 million in COVID-related development and humanitarian assistance through USAID, the U.S. Department of Defense, the U.S. Department of State, and the U.S. Centers for Disease Control and Prevention.  This assistance has saved lives and treated individuals infected with COVID-19, strengthened testing capacity and monitoring, enhanced case management and infection prevention and control practices, and improved the supply chain and logistics management systems.  U.S. support has also "protected" front line workers and increased the public’s knowledge on how to better protect themselves from infection. The United States has donated $4 billion to support the worldwide COVAX effort, which includes support for ultra-cold chain storage, transportation, and safe handling of COVID-19 vaccines, making the United States the world’s largest donor for equitable global COVID-19 vaccine access.

The United States on Saturday donated 9.6 million doses of Pfizer’s COVID-19 vaccine to Bangladesh, a gift from the American people. This donation of Pfizer vaccine brings the overall U.S. government vaccine contribution to over 28 million doses. “Nothing has made me prouder as U.S. Ambassador to Bangladesh over the past three years than the work we are doing together to combat the COVID-19 pandemic," said US Ambassador to Bangladesh Earl R Miller. He said he is pleased to announce, through the generosity of the American people, a donation of 9.6 million additional vaccine doses to the people of Bangladesh. Also read: Another 2.4 million Pfizer jabs received from US "The United States has now donated, free for charge, over 28 million vaccine doses to Bangladesh with millions more on the way. We salute and stand with heroic Bangladeshi health care providers and assistance partners as we work together to provide a healthier, brighter future for the people of both our great nations,” said outgoing Ambassador Miller. This delivery of Pfizer vaccine doses is part of the United States’ commitment to lead the global COVID-19 response by donating a billion doses of Pfizer vaccine around the world through 2022. In addition to vaccine donations, the United States continues to work closely with Bangladesh to support the national COVID-19 vaccination campaign and strengthen the government’s response to the pandemic, said the US Embassy in Dhaka.  The United States has provided training to over 7,000 healthcare providers on the proper management and administration of vaccines. To date, the United States has contributed over $121 million in COVID-related development and humanitarian assistance through USAID, the U.S. Department of Defense, the U.S. Department of State, and the U.S. Centers for Disease Control and Prevention.   Also read: Pfizer pill becomes 1st US-authorized home COVID treatment This assistance has saved lives and treated individuals infected with COVID-19, strengthened testing capacity and monitoring, enhanced case management and infection prevention and control practices, and improved the supply chain and logistics management systems.  U.S. support has also protected front line workers and increased the public’s knowledge on how to better protect themselves from infection. The United States has donated $4 billion to support the worldwide COVAX effort, which includes support for ultra-cold chain storage, transportation, and safe handling of COVID-19 vaccines, making the United States the world’s largest donor for equitable global COVID-19 vaccine access.

Bangladesh has received 1.8 million more Pfizer vaccine jabs donated by the United States as part of its broader commitment to lead the global Covid-19 response. The new doses will help the government of Bangladesh continue expanding the Covid-19 vaccinations for young people ages 12 and up and reach its goal of vaccinating 40 percent of the eligible population by the end of 2021, said the US Embassy in Dhaka on Wednesday. The donation of Pfizer jabs is part of the broader commitment by the United States to lead the global Covid-19 response by providing one billion doses of Pfizer vaccine doses around the world—free of charge—through 2022, it said. The United States is also working closely with Bangladesh to support the national Covid-19 vaccination campaign and strengthen the government’s response to the pandemic.   Also Read: Pfizer says COVID-19 pill cut hospital, death risk by 90% The US has provided training to over 6,800 healthcare professionals to help them safely administer vaccines and donated 18 cold-chain freezer trucks and support for health facilities to properly store and transport Covid-19 vaccines across the country.   In addition to vaccine donations and support, the US government has contributed over $121 million in Covid-related assistance.   This assistance has saved lives and treated individuals infected with Covid-19, strengthened testing capacity and monitoring, enhanced case management and infection prevention and control practices, and improved the supply chain and logistics management systems, said the Embassy.   US support also protects frontline workers and increases the public’s knowledge about Covid-19, including ways to protect themselves. Also Read: FDA paves way for Pfizer COVID-19 vaccinations in young kids The United States has donated $4 billion to support the worldwide Covax efforts, which includes support for ultra-cold chain storage, transportation, and safe handling of Covid-19 vaccines, making the United States the world’s largest donor for equitable global Covid-19 vaccine access.

Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group. The shots could begin in early November, with the first children in line fully protected by Christmas, if regulators give the go-ahead. That would represent a major expansion of the nation’s vaccine drive, encompassing roughly 28 million elementary school-age youngsters. Details of Pfizer’s study were posted online. The Food and Drug Administration was expected to post its own review of the company’s safety and effectiveness data later in the day. Advisers to the FDA will publicly debate the evidence next week. If the agency itself authorizes the shots, the Centers for Disease Control and Prevention will make the final decision on who should receive them. Full-strength Pfizer shots already are authorized for anyone 12 or older, but pediatricians and many parents are anxiously awaiting protection for younger children to stem rising infections and record hospitalizations among them from the extra-contagious delta variant and to help keep kids in school. The Biden administration has purchased enough kid-size doses — in special orange-capped vials to distinguish them from adult vaccine — for the nation’s 5- to 11-year-olds. If the vaccine is cleared, millions of doses will be promptly shipped around the country, along with kid-size needles. Read: Pfizer's request to OK shots for kids a relief for parents More than 25,000 pediatricians and primary care providers already have signed up to get the shots into little arms. The Pfizer study tracked 2,268 children in the 5-to-11 group who got two shots three weeks apart of either a placebo or the low-dose vaccine. Each dose was one-third the amount given to teens and adults. Researchers calculated the low-dose vaccine was nearly 91% effective, based on 16 COVID-19 cases in youngsters given dummy shots versus three cases among vaccinated children. There were no severe illnesses reported among any of the youngsters, but the vaccinated ones had much milder symptoms than their unvaccinated counterparts. Most of the study data was collected in the U.S. during August and September, when the delta variant had become the dominant COVID-19 strain. In addition, young children given the low-dose shots developed coronavirus-fighting antibody levels just as strong as teens and young adults who got regular-strength vaccinations. In another piece of encouraging news, the CDC reported earlier this week that even as the delta variant surged over the summer, Pfizer vaccinations were 93% effective at preventing hospitalizations among 12- to 18-year-olds. Read: World could return to normal within a year: Pfizer CEO Pfizer’s study of younger children found the low-dose shots proved safe, with similar or fewer temporary side effects such as sore arms, fever or achiness that teens experience. The study isn’t large enough to detect any extremely rare side effects, such as the heart inflammation that occasionally occurs after the second dose, mostly in young men. While children run a lower risk of severe illness or death than older people, COVID-19 has killed more than 630 Americans 18 and under, according to the CDC. Nearly 6.2 million children have been infected with the coronavirus, more than 1.1 million in the last six weeks as the delta variant surged, the American Academy of Pediatrics says. Moderna also is studying its COVID-19 shots in elementary school-age youngsters. Pfizer and Moderna are studying even younger children as well, down to 6-month-olds. Results are expected later in the year.

Some 25 lakh more doses of the Pfizer vaccine arrived in Dhaka early on Tuesday morning, under the COVAX initiative. A cargo flight of National Airlines, carrying the vaccine doses gifted by the US, landed at Hazrat Shahjalal International Airport arround 5am, Health Ministry officials said. Senior officials of the Health Ministry, the health department, Central Medical Stores Depot (CMSD) and the airport authority were present to take the delivery of the jabs. Read: World could return to normal within a year: Pfizer CEO "Pleased to announce the arrival of another 2.5 million doses of Pfizer vaccine," said US Ambassador to Bangladesh Earl R Miller.  This brings the total US vaccine donation to 9 million, with more on the way very soon, he said.  These are a gift from the USA to Bangladesh, said the envoy. "Alongside $96 million,  continue to stand together to fight COVID-19," he said. Earlier, Bangladesh received over 1 lakh doses of the Pfizer vaccine in the first phase and 10.03 lakh doses in the second phase from the US. With the arrival of the fresh batch, Bangladesh has received a total of 36.04 lakh doses of the vaccine to date. So far, the country has received 4.94 crore doses of AstraZeneca, Sinopharm and Moderna vaccines under the COVAX facility.  According to the Health Ministry, some 2,48,80,898 people got their first Covid shot while 1,64,99,866 were administered the second dose till September 27. Besides, a process to import some two crore doses of the Chinese Sinopharm vaccine each month is underway. Apart from this, another process to procure 24 crore doses of the vaccine through the World Health Organisation is going on.  Read: Dhaka to receive another 25 lakh Pfizer vaccine doses Monday

Twenty-five lakh more doses of Pfizer vaccine under COVAX facility are scheduled to reach Dhaka on Monday. A cargo flight of National Airlines, carrying the vaccine doses gifted by the USA, will land at the Hazrat Shahjalal International Airport around 10:15 PM, said officials at the Health Ministry. Read:Bangladesh to get 71 lakh Pfizer, 18 lakh Moderna jabs: Shahriar US Ambassador to Bangladesh Earl R Miller and DG of the Director General of Health Services (DGHS) Dr Abul Bashar Mohammad Khurshid Alam will be present at the airport to receive the vaccine jabs. Earlier, Bangladesh received over 1 lakh doses of Pfizer vaccine in the first phase and 10.03 lakh doses in the second phase from the US. With the fresh batch, Bangladesh will receive a total of 36.04 lakh doses of the vaccine. Read: Pfizer says COVID-19 vaccine works in kids ages 5 to 11 So far, the country has received 4.94 crore doses of Astra Zeneca, Sinopharm and Moderna vaccines under COVAX facility. Of these, 2,41,97,598 people got their first dose while 1,60,33,971 the second dose till September 25, according to the Health Ministry. Besides, a process to bring 2 crore doses of Sinopharm vaccine each month is underway. Apart from this, another process to procure 24 crore doses of vaccine through the World Health Organisation is going on. Bangladesh started administering the first doses of Pfizer-BioNTech vaccine at three centres in Dhaka to fight off Covid-19 on June 21. Read: US assures Covid cooperation to continue as 1-mn doses of Pfizer's vaccine received The United States said it is committed to leading the global response to the Covid-19 pandemic and they will begin this summer the allocation of 500 million doses of the Pfizer vaccine it is providing to Gavi for distribution by COVAX to countries around the world.  US President Joe Biden reaffirmed this commitment by announcing that his country will donate 80 million doses of vaccines to support global needs.  The US is working with its G7 partners, the EU, COVAX, and others in a multilateral effort focused on saving lives, ending the pandemic, and supporting the global economic recovery.  

US Ambassador to Bangladesh Earl R. Miller and Senior Secretary of the Health Service Division Lokman Hossian Miah on Wednesday welcomed the arrival of one million doses of Pfizer’s COVID-19 vaccine in Bangladesh. The vaccine doses are donated by the United States as part of the U.S. Government’s commitment to donate 500 million doses of the Pfizer vaccine globally. Bangladesh is expected to receive another 5 million doses of the same vaccine from the US this month. They build on earlier donations of the Moderna vaccine, for a total of 6.5 million doses gifted by the U.S. Government and the American people to the people of Bangladesh. Director General of the Directorate General of Health Services (DGHS) Professor Abul Bashar Mohammad Khurshid Alam and U.S. Agency for International Development (USAID) Mission Director Kathryn Stevens were also present at Hazrat Shahjalal International Airport to receive the shipment of vaccines, facilitated through COVAX. Read: Covid positivity rate shrinks to 10%, cases and deaths continue declining

Another 10 lakh doses of Pfizer vaccine from COVAX facility will reach Bangladesh on August 30, said Health Minister Zahid Maleque on Tuesday. The Pfizer vaccine doses, gifted by the US, are scheduled to arrive at the Hazrat Shahjalal International Airport around 7:15 PM by a Qatar Airways flight, he said while talking to reporters at the Secretariat. Read:US regulators give full approval to Pfizer COVID-19 vaccine Foreign Minister Dr AK Abdul Momen and US Ambassador to Bangladesh Earl R Miller and the health minister will be present at the airport to receive the vaccine jabs. Earlier, the health minister said Bangladesh will receive 60 lakh more Pfizer jabs from COVAX facility. Another 50 lakh doses will arrive in Bangladesh in phases by September, he said.   Bangladesh started administering the first doses of Pfizer-BioNTech vaccine at three centres in Dhaka to fight off Covid-19 on June 21. The United States said it is committed to leading the global response to the Covid-19 pandemic and they will begin this summer the allocation of 500 million doses of the Pfizer vaccine it is providing to Gavi for distribution by COVAX to countries around the world.  Read: Bangladesh to receive 60 lakh more Pfizer vaccine doses in Aug: Minister US President Joe Biden reaffirmed this commitment by announcing that the US will donate 80 million doses of vaccines to support global needs.  The US is working with its G7 partners, the EU, COVAX, and others in a multilateral effort focused on saving lives, ending the pandemic, and supporting the global economic recovery.  

Bangladesh will receive 60 lakh more doses of Pfizer vaccine from COVAX facility by early August, said Health Minister Zahid Maleque on Saturday. The minister said this while talking to reporters after visiting a field hospital at Bangabandhu Sheikh Mujib Medical College convention centre. Read: Bangladesh rolls out Pfizer vaccine at 3 Dhaka centers Minister Maleque said the World Health Organization (WHO) has confirmed the vaccine delivery information on Friday through a letter. “By the end of July or in the beginning of August, we’ll receive 50 lakh doses of Covid-19 vaccine from China, too,” Zahid Maleque added. “We’re hopeful of having 1 to 1.5 crore doses of vaccines in our stock within one and a half months. More vaccines will be coming in August,” he said. Read: Pfizer, Sinopharm shots to start June 19: Health Minister The minister urged everyone to show compassion to   doctors and health workers who are in the frontline in the fight against Covid-19 serving patients round the clock, and many of them have lost their lives, too.   Read: Registered people will get Pfizer vaccine first, says health minister

As Covid-19 is continuing to spread around the world the caseload has crossed 1758.4 million. The total caseload and fatalities stand at 178,424, 674 and 3,864,442 respectively as of Monday morning. The latest figures have been released by Johns Hopkins University (JHU). So far, 2,600, 035,128 vaccine doses have been administered across the globe. Read:Global hunger levels rise as conflict, climate shocks and Covid collide The US, which is the world's worst-hit country in terms of both cases and deaths, has so far logged 33,541,889 cases, according to JHU. Besides, 601,826 people have lost their lives in the US to date. Brazil is experiencing a new wave of infections in hospitals as the country has registered 1,025 more deaths from Covid-19 in the past 24 hours, bringing the national death toll to 501,825, the health ministry said Sunday. A total of 44,178 new infections were detected, raising the total caseload to 17,927,928, the ministry said. Brazil has the world's second highest Covid-19 death toll, after the United States, and the third largest caseload, following the United States and India. Read: Bangladesh reports alarming 82 Covid deaths, highest in 52 days India's Covid-19 tally rose to 29,881,772 on Monday with 386,708 fatalities. Situation in Bangladesh As the Covid-19 situation in Bangladesh has taken a turn for the worse again, 82 more people died of coronavirus in 24 hours until Sunday morning. This is the highest daily death toll in the last 52 days as the country logged 88 deaths on April 29 this year. During the period, 3,641 more Covid cases were detected after the test of 22,231 samples, said a handout issued by the Directorate General of Health Services (DGHS). With the new numbers, the country’s caseload now stood at 851,668 while the death toll at 13,548, said the DGHS handout. Read: Covid claims three lives, infects 102 others in Chapainawabganj Bangladesh is now administering the 1st doses of Sinopharm vaccine and the second dose of Oxford-AstraZeneca vaccine.It will start administering Pfizer vaccine Monday. So far 3,720 people received the first dose of China’s Sinopharm vaccine, including 764 in the past 24 hours. Of the Astrazeneca vaccine, 4,270,322 people received the second shot and 5,820,015 the first one so far.